ACMG 2017
Find PierianDx in both the New Product Showcase exhibit and booth #511

to PierianDx

If you operate a clinical lab seeking to build or expand your genomic testing, we can help. PierianDx provides the most comprehensive, robust and integrated solution for Next Generation Sequencing (NGS) that enables labs to quickly go from raw sequencing data to actionable, informed patient diagnosis and treatment.

Learn More

Who We Serve

PierianDx enables academic medical centers, health systems, children’s hospitals, comprehensive cancer centers and commercial labs to accelerate their precision medicine initiatives. If you are looking to bring clinical testing in-house rapidly or one step at a time, we have the right solution for you.


Enabling Personalized Medicine – Then and Now

When it comes to precision medicine, we’ve been there from the beginning. Our legacy is tied to Washington University in St. Louis and expertise created through the Human Genome Project. Our platform was inspired by a team of pathology, genetics, and informatics experts with a sole focus on clinical tools. Since then, clinical labs worldwide have adopted our software platform and NGS testing services. Want to be part of our history?


Learn More

Our Services.

Comprehensive Platform. Flexible Engagement Model.

PierianDx’s clinical workspace provides a portfolio of tools and services to enable or accelerate NGS testing initiatives.


  • “Being able to better analyze DNA and genetic markers through PierianDx’s products will help us improve our patient-centered care, including diagnosis and treatment. Through sharing clinical interpretations, we expect to gain meaningful insights that could lead to better patient outcomes.”

    Anthony Magliocco, M.D., Department Chair of Pathology at Moffitt

  • “Phoenix Children’s has a unique approach to these highly comprehensive genomic analyses-driven clinical trials for pediatric patients. Drug development for pediatric cancers is an area that has not received due attention, so we are hopeful that with this approach, many new treatment options for children suffering from various types of cancer will be identified.”

    Dr. Nazneen Aziz, Chief Research Officer for Phoenix Children’s Hospital

  • “We are very excited to join the network of partners using PierianDx’s genetic software services. The software will help us to streamline the reporting of genomic profiling results to our physicians and will facilitate the curation of a clinical grade variant database at the University of Arizona. Not only will this partnership aid our oncologists in the pursuit of better treatments for their cancer patients today, this will provide unprecedented opportunities to match the right patient with the right treatment, and ultimately improve the outcome for many patients in the years to come.”

    Dr. Michael Hammer, Director of the University of Arizona Genetics Core

  • “Our partnership with PierianDx will supply healthcare systems’ in-house labs with a simpler and more integrated workflow. The PierianDx bioinformatics platform and testing services will ultimately speed the delivery of precision care to patients.”

    Jonathan Hirsch, Founder & President of Syapse


When it comes to genomic data analysis, interpretation and reporting, knowledge is power. PierianDx’s Collaborative Knowledgebase is the most powerful genomic data engine in the industry. Our constantly expanding molecular medical knowledgebase enables effective, data-driven reproducible clinical decision-making

Recent News


Doctors Use Computers More and Microscopes Less to Find Future Cancer Treatments

December 6, 2016
Not long ago, doctors hoping to cure human disease spent a lot of time in the laboratory looking through microscopes.
Read More

PierianDx Acquires Tute Genomics

October 11, 2016
Company Extends Ability to Deliver a Unified Sample-to-Report Software Platform for Clinical Labs PierianDx, the forerunner in clinical genomic analysis, interpretation
Read More

PierianDx Named to CIOReview’s 20 Most Promising Cloud Solution Providers 2016

August 30, 2016
ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, was recently included in a list of
Read More

PierianDx and ArcherDX Announce Partnership Benefiting NGS Clinical Labs

July 19, 2016
ST LOUIS/BOULDER – ArcherDX and PierianDx today announced co-marketing and licensing agreements that will provide enhanced NGS testing capabilities to
Read More

PierianDx Announces 10 New Customers in Q1 2016, Expands Partner Sharing Network to 24 Members

April 28, 2016
ST. LOUIS, MO  – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced it has added several new
Read More
Researcher at work

PierianDx Announces Two New Board Members; Bryan Carey and Frederick Hessler Bring Vast Healthcare Experience

March 22, 2016
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that Bryan J. Carey and
Read More

PierianDx Closes Series A Financing Led by Health Catalyst Capital Management; Company Poised for Next Stage of Growth

January 7, 2016
PierianDx, the leading provider of genomic software and services to enable data-driven personalized medicine, announced that it closed $9.25 million in Series A financing
Read More
Scientist at work in a laboratory

PierianDx and Syapse Partner to Accelerate Precision Medicine Programs for Healthcare Providers

October 29, 2015
ST. LOUIS, MO and PALO ALTO, CA – PierianDx, makers of the leading bioinformatics platform for clinical genomics testing, and
Read More

Aeon Clinical Laboratories Leverages PierianDx Bioinformatics Platform to Enhance Genomic Test Offering

October 13, 2015
ST LOUIS, MO/GAINSVILLE, GA – PierianDx, the forerunner in clinical genomic informatics, and Aeon Clinical Laboratories, one of the fastest
Read More

MDL Partners with PierianDx to Rapidly Launch Next Generation Sequencing Tests for Breast Cancer

August 25, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that Molecular Diagnostics Laboratories (MDL) has standardized
Read More
Lab tech setting up PCR reaction for whole exome samples

PierianDx Launches Exome Next Generation Sequencing Offering; Leading Medical Experts Shape Platform Functionality

August 13, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that it has released a new version
Read More

PierianDx Builds Leadership Team to Accommodate Fast Growth Jim Howard Joins as Senior VP Sales

April 23, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that healthcare entrepreneur Jim Howard is joining
Read More

PierianDx Plans Software Update to Improve Variant Prioritization, Clinical Relevance Assessment

April 2, 2015
NEW YORK (GenomeWeb) – This summer, PierianDx plans to add a so-called PDx score to the next iteration of Clinical
Read More

PierianDx Introduces PDx Score to Quickly Prioritize Actionable Variants, While Expanding Industry-Leading Knowledgebase

March 24, 2015
ST LOUIS, MO –  PierianDx announced today that its genomic testing platform will soon produce a PDx Score giving clinicians
Read More

UVA to use PierianDx Platform to Analyze, Report on Cancer Patients’ Genome Data

February 23, 2015
ST LOUIS, MO and CHARLOTTESVILLE, VA – PierianDx announced today that the University of Virginia Health System has joined the
Read More

Inova Joins PierianDx Partner Network to Provide Precision Medicine to Cancer Patients

February 19, 2015
ST LOUIS, MO and FALLS CHURCH, VA – PierianDx announced today that the Inova Translational Medicine Institute has joined the
Read More

ARUP Introduces NGS.Web, a Powerful Next-Generation Sequencing Platform

January 21, 2015
January 21, 2015—ARUP Laboratories, a national nonprofit reference laboratory, announced today the implementation of NGS.Web, a powerful next-generation sequencing (NGS) platform. This innovative platform will enhance sample tracking, data analysis, and reporting of genetic and oncological sample testing.
Read More
dna-gene-1024x576 (1)

PierianDx Launches NGS Gateway Program

November 17, 2014
PierianDx, the forerunner in clinical genomic informatics, announced the PDX NGS Gateway Program, a service designed to enable partner personalized medicine initiatives.
Read More

PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing

September 2, 2014
PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing. College of American Pathologists’
Read More

PierianDx Launches the Clinical Genomicist Workstation for SaaS NGS Analysis

July 23, 2014
By Allison Proffitt, Clinical Informatics News Washington University is throwing its hat in the clinical sequencing ring with a...
Read More

Moffitt Cancer Center and the University of Vermont Join PierianDx Partner Network

July 17, 2014
ST LOUIS – PierianDx announced today that Moffitt Cancer Center in Tampa, FL and Fletcher Allen...
Read More

PierianDx Licenses Diagnostic Genetic Sequencing Products from Washington University in St. Louis

June 30, 2014
ST. LOUIS, MO – PierianDx announced today that it has exclusively licensed from Washington University in St. Louis a proprietary
Read More

Journal of Molecular Diagnostics

June 1, 2014
PierianDx Medical Advisor, Catherine Cottrell, Ph.D., FACMG, publishes an article in the Journal of Molecular Diagnostics describing the validation and
Read More

Clinical NGS WUSTL

January 1, 2014
Rakesh Nagarajan, M.D., PhD., PierianDx Founder and Chief BioMedical Informatics Officer presents at the Cancer Informatics for Cancer Centers Spring 2014 Conference at the Meritage Conference Center in Napa Valley, California.
Read More

Contact Us

Let’s Personalize Medicine Together.


77 Maryland Plaza,
St. Louis, Missouri 63108